跳至主要内容
临床试验/SLCTR/2019/038
SLCTR/2019/038尚未招募2 期

Comparison of Delta-tocotrienol and Alpha-tocopherol Effects on Biochemical Markers, Micro-RNA Expression and Hepatic Steatosis in Patients with Non-Alcoholic Fatty Liver Disease

ational University of Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Both men and women
  • 2. Aged 20-70 years
  • 3. Presence of fatty liver on abdominal CT scan with a liver to spleen (L/S) attenuation ratio of less than
  • 1.1 (indicating more than 30% hepatic steatosis)
  • 4. Fatty Liver Index (FLI) of equal to or more than 60
  • 5. Alanine transaminase (ALT) within reference range or mildly raised i.e. not greater than 3 times the
  • upper limit of 42 IU/L in male and 36 IU/L in female

排除标准

  • 1. Chronic hepatitis B and C
  • 2. Alcoholic fatty liver Disease
  • 3. Autoimmune liver disease
  • 4. History or clinical evidence of liver cirrhosis
  • 5. Hemochromatosis, Wilson’s disease
  • 6. Diabetic patients with Hemoglobin A1c (HbA1c) more than 8.5%
  • 7. A history of cardiovascular disease, pulmonary disease & renal disease
  • 9. Pregnant or lactating females or females planning to become pregnant during the study period
  • Patients on oral insulin-sensitizing agents, herbs and vitamin supplements
  • 10.Patients under treatment with tamoxifen, methotrexate, amiodarone, diltiazem or other drugs able to
  • induce fatty liver

研究者

发起方
ational University of Medical Sciences

相似试验